Evidence map›Paper›PMID 41886751›Full record

ReviewJournal of medical Internet research2026

Deep Research Agents: Major Breakthrough or Incremental Progress for Medical AI?

Matthew Yu Heng Wong, Ariel Yuhan Ong, David A Merle, Pearse A Keane

Abstract readReview
In one paragraph

Review in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew Yu Heng WongSchool of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Rd, Cambridge, CB2 0SP, United Kingdom, 44 07888263149.ORCID http://orcid.org/0009-0004-7633-4901
Ariel Yuhan OngNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.ORCID http://orcid.org/0000-0001-9300-573X
David A MerleNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.ORCID http://orcid.org/0000-0003-4485-5580
Pearse A KeaneNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.ORCID http://orcid.org/0000-0002-9239-745X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: Deep research agents are autonomous large language model-based systems capable of iterative web search, retrieval, and synthesis. They are increasingly positioned as the next major leap in medical artificial intelligence. In this viewpoint, we argue that while these agents mark progress in information access and workflow automation, they represent an incremental evolution rather than a paradigm shift. We review current applications of deep research agents in biomedical scenarios, including literature review generation, clinical evidence synthesis, guideline comparison, and patient education. Across these early use cases, the tools demonstrate the ability to rapidly gather and structure up-to-date information, often producing outputs that appear comprehensive and well-referenced. However, these strengths coexist with unresolved and clinically significant limitations. Citation fidelity remains inconsistent across models, with subtle misinterpretations or unreliable references still common. Their retrieval processes and evidence-ranking mechanisms remain opaque, raising concerns about reproducibility and hidden biases. Moreover, overreliance on artificial intelligence-generated syntheses risks eroding clinicians' critical appraisal skills and may introduce automation bias at a time when medicine increasingly requires deeper scrutiny of information sources. Safety constraints are also less predictable within multistep research pipelines, increasing the risk of harmful or inappropriate outputs. Finally, current evidence is largely limited to proof-of-concept evaluations, with little evidence from real-life clinical deployment. We contend that deep research agents should be embraced as assistive research tools rather than pseudoexperts. Their value lies in accelerating information gathering, not replacing rigorous human judgment. Realizing their potential will require transparent retrieval architectures, robust benchmarking, and explicit educational integration to preserve clinicians' evaluative reasoning. Used judiciously, these systems could enrich medical research and practice; used uncritically, they risk amplifying errors at scale. We contend that deep research agents should be embraced as assistive research tools rather than pseudoexperts. Their value lies in accelerating information gathering, not replacing rigorous human judgment. Realizing their potential will require transparent retrieval architectures, robust benchmarking, and explicit educational integration to preserve clinicians' evaluative reasoning. Used judiciously, these systems could enrich medical research and practice; used uncritically, they risk amplifying errors at scale.

Indexed as

Artificial IntelligenceGenerative Artificial IntelligenceHumansLarge Language ModelsAIartificial intelligencelarge language modelsLLMsmedical researchscientific writing

Identifiers

PMID41886751
PMCPMC13021100

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.